281 related articles for article (PubMed ID: 10960882)
1. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
[TBL] [Abstract][Full Text] [Related]
2. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
Fry J; Scharf M; Mangano R; Fujimori M
Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
[TBL] [Abstract][Full Text] [Related]
3. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
4. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
5. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
Weitzel KW; Wickman JM; Augustin SG; Strom JG
Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
Huang YS; Hsu SC; Liu SI; Chen CK
Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
[TBL] [Abstract][Full Text] [Related]
7. Benefit-risk assessment of zaleplon in the treatment of insomnia.
Barbera J; Shapiro C
Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
[TBL] [Abstract][Full Text] [Related]
8. Safety of zaleplon in the treatment of insomnia.
Israel AG; Kramer JA
Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of sedative hypnotics in older patients with insomnia.
Ancoli-Israel S; Richardson GS; Mangano RM; Jenkins L; Hall P; Jones WS
Sleep Med; 2005 Mar; 6(2):107-13. PubMed ID: 15716214
[TBL] [Abstract][Full Text] [Related]
10. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
11. Treatment of insomnia with zaleplon, a novel sleep medication.
Doghramji PP
Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
[TBL] [Abstract][Full Text] [Related]
12. Zaleplon improves sleep quality in maintenance hemodialysis patients.
Sabbatini M; Crispo A; Pisani A; Ragosta A; Cesaro A; Mirenghi F; Cianciaruso B; Federico S
Nephron Clin Pract; 2003; 94(4):c99-103. PubMed ID: 12972720
[TBL] [Abstract][Full Text] [Related]
13. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
14. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
[TBL] [Abstract][Full Text] [Related]
15. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
Rosenberg RP
Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
[TBL] [Abstract][Full Text] [Related]
16. Management of insomnia--the role of zaleplon.
Richardson GS; Roth T; Kramer JA
MedGenMed; 2002 Mar; 4(1):9. PubMed ID: 11965211
[TBL] [Abstract][Full Text] [Related]
17. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
Heydorn WE
Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
[TBL] [Abstract][Full Text] [Related]
18. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.
Huedo-Medina TB; Kirsch I; Middlemass J; Klonizakis M; Siriwardena AN
BMJ; 2012 Dec; 345():e8343. PubMed ID: 23248080
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of zaleplon at peak plasma levels.
Mangano RM
Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]